A patient with medullary thyroid carcinoma and right ventricular cardiac metastasis treated by (90)Y-Dotatoc

Hell J Nucl Med. 2009 May-Aug;12(2):161-4.

Abstract

Medullary thyroid carcinoma (MTC) is rare derived from C cells of the thyroid gland and represents approximately 5% of all thyroid carcinomas. We report a case of a 74 years old male with MTC, diagnosed in 2002 and treated with total thyroidectomy and lymphadenectomy. A metastatic lesion was diagnosed on the right ventricle by indium-111-octreoscan, fluorine-18-fluorodeoxyglucose-positron emission tomography/computerized tomography, echocardiography, magnetic resonance imaging, high resolution computed tomography and was confirmed by histopathology. We present the results of treatment of this patient with yttrium-90-DOTA-tyr(3)-octreotide.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Medullary / radiotherapy*
  • Carcinoma, Medullary / secondary*
  • Heart Neoplasms / radiotherapy*
  • Heart Neoplasms / secondary*
  • Heart Ventricles*
  • Humans
  • Male
  • Octreotide / analogs & derivatives*
  • Octreotide / therapeutic use
  • Radiopharmaceuticals / therapeutic use
  • Thyroid Neoplasms / radiotherapy*
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • 90Y-octreotide, DOTA-Tyr(3)-
  • Octreotide